{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:Q07869",
      "entity_text" : "PPARalpha",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "TissueType" : [ "tissuelist:TS-0079" ],
      "Species" : [ "taxonomy:9606" ]
    }
  },
  "verbose_text" : "Subjects exposed to AhR agonists and exhibiting high blood levels of endogenous PPARalpha ligands would therefore be expected to present a greater risk of developing intestinal or pulmonary cancers and/or other diseases related to CYP1A1 overexpression.",
  "reading_complete" : "2020-08-08T13:46:17Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T13:45:29Z",
  "trigger" : "levels",
  "evidence" : [ "levels of endogenous PPARalpha" ],
  "pmc_id" : "3031628",
  "score" : 0
}